Artesunate targets oral tongue squamous cell carcinoma via mitochondrial dysfunction-dependent oxidative damage and Akt/AMPK/mTOR inhibition
2020 ◽
Vol 52
(2)
◽
pp. 113-121
◽
Keyword(s):
2016 ◽
Vol 17
(1)
◽
pp. 189-195
◽
2016 ◽
Vol 69
(10)
◽
pp. 942-945
◽
Keyword(s):
2018 ◽
Vol 17
(6)
◽
pp. 2045-2059
◽